Susan Hasty, Publisher
Table of Contents . . . March 4th, 2000Non-Subscriber - Summaries Only
Chemotherapy - Encouraging Results Reported for New Breast Cancer Therapy
Clinical Trials - Elderly Population Significantly Underrepresented in Cancer Studies
Drug Development - Are Smaller Antibodies Better?
Drug Interactions - Docetaxel May Interfere with Epirubicin Plasma Level
Genetic Risk - Tumor Phenotype Associated With BRCA1 Mutations
Mammography - Attitudes Correlate to Screening
Lipid Metabolism (NIH Grant News) - Study Will Look at Role of Lipid Metabolites in Breast Cancer
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.